Wen Xia

1.9k total citations
88 papers, 1.2k citations indexed

About

Wen Xia is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Wen Xia has authored 88 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 24 papers in Molecular Biology and 22 papers in Cancer Research. Recurrent topics in Wen Xia's work include Drug Transport and Resistance Mechanisms (17 papers), Advanced Breast Cancer Therapies (13 papers) and Breast Cancer Treatment Studies (12 papers). Wen Xia is often cited by papers focused on Drug Transport and Resistance Mechanisms (17 papers), Advanced Breast Cancer Therapies (13 papers) and Breast Cancer Treatment Studies (12 papers). Wen Xia collaborates with scholars based in China, United States and Netherlands. Wen Xia's co-authors include Lauren M. Aleksunes, Melanie S. Joy, Shusen Wang, Kristin M. Bircsak, Zhongyu Yuan, Fei Xu, Xin Hua, Qiufan Zheng, Ruoxi Hong and Brian Buckley and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The FASEB Journal.

In The Last Decade

Wen Xia

80 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Xia China 23 477 434 229 196 131 88 1.2k
Barry Hoffman Canada 18 545 1.1× 519 1.2× 244 1.1× 127 0.6× 83 0.6× 30 1.5k
Araba A. Adjei United States 19 377 0.8× 616 1.4× 145 0.6× 214 1.1× 172 1.3× 32 1.3k
Christelle Cauffiez France 23 239 0.5× 720 1.7× 351 1.5× 148 0.8× 99 0.8× 60 1.5k
Alice A. Gibson United States 23 790 1.7× 391 0.9× 108 0.5× 158 0.8× 180 1.4× 46 1.4k
Nigel T. Brockton Canada 22 544 1.1× 639 1.5× 277 1.2× 129 0.7× 89 0.7× 42 1.6k
Yaping Song China 22 282 0.6× 524 1.2× 341 1.5× 97 0.5× 98 0.7× 77 1.2k
Jason R. Manro United States 14 556 1.2× 420 1.0× 104 0.5× 158 0.8× 86 0.7× 28 1.3k
Daniel J. Crona United States 17 248 0.5× 350 0.8× 133 0.6× 494 2.5× 196 1.5× 51 1.2k
Delores J. Grant United States 17 202 0.4× 322 0.7× 157 0.7× 155 0.8× 62 0.5× 30 864
Justin Taylor United States 18 276 0.6× 708 1.6× 172 0.8× 85 0.4× 167 1.3× 79 1.7k

Countries citing papers authored by Wen Xia

Since Specialization
Citations

This map shows the geographic impact of Wen Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Xia more than expected).

Fields of papers citing papers by Wen Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Xia. The network helps show where Wen Xia may publish in the future.

Co-authorship network of co-authors of Wen Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Xia. A scholar is included among the top collaborators of Wen Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Xia. Wen Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghimire, Anukul, Wen Xia, Cathleen Doherty, et al.. (2024). Population Pharmacokinetic Model of Platinum Disposition in Cancer Patients Receiving Cisplatin and Randomized to 5‐HT3 Antagonist Antiemetic Drugs. The Journal of Clinical Pharmacology. 65(6). 763–778. 1 indexed citations
2.
Jiang, Kuikui, Ruoxi Hong, Qianyi Lu, et al.. (2023). Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors. Journal of Personalized Medicine. 13(2). 365–365.
3.
Duan, Fangfang, Chenge Song, Jiajia Huang, et al.. (2022). Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study. Journal of Oncology. 2022. 1–10. 1 indexed citations
4.
Hong, Ruoxi, Wen Xia, Liye Wang, et al.. (2021). Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study. Cancer Communications. 41(2). 171–182. 23 indexed citations
5.
Xia, Wen, Ranran Zhang, Cathleen Doherty, et al.. (2021). BCRP/ABCG2 Transporter Regulates Accumulation of Cadmium in Kidney Cells: Role of the Q141K Variant in Modulating Nephrotoxicity. Drug Metabolism and Disposition. 49(8). 629–637. 8 indexed citations
6.
Li, De‐Pei, Wanming Hu, Xiaoping Lin, et al.. (2021). CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas. Frontiers in Cell and Developmental Biology. 9. 653240–653240. 2 indexed citations
7.
Gu, Wenchao, Wen Xia, Yan Gong, et al.. (2021). METTL3 Is Suppressed by Circular RNA circMETTL3/miR-34c-3p Signaling and Limits the Tumor Growth and Metastasis in Triple Negative Breast Cancer. Frontiers in Oncology. 11. 778132–778132. 17 indexed citations
8.
Lu, Qianyi, Fei Xu, Wen Xia, et al.. (2020). Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center. Cancer Communications. 40(5). 222–233. 15 indexed citations
9.
Wang, Xinyue, Jibin Li, Wei Shi, et al.. (2020). Efficacy of Moxifloxacin plus Treatment of Physician's Choice in Patients with Metastatic Breast Cancer. The Oncologist. 25(10). e1439–e1445. 5 indexed citations
10.
11.
Wang, Ning, Hor‐Yue Tan, Sha Li, et al.. (2019). SBP2 deficiency in adipose tissue macrophages drives insulin resistance in obesity. Science Advances. 5(8). eaav0198–eaav0198. 21 indexed citations
12.
Zhang, Kai, Ruoxi Hong, Fei Xu, et al.. (2019). CDK4/6 inhibitor palbociclib enhances the effect of pyrotinib in HER2-positive breast cancer. Cancer Letters. 447. 130–140. 35 indexed citations
13.
Ibrahim, Mustafa E., Yichun Hu, Susan L. Hogan, et al.. (2018). Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patients. European Journal of Clinical Pharmacology. 75(1). 51–57. 29 indexed citations
14.
Lu, Qianyi, Tao Qin, Fei Xu, et al.. (2018). Clinical implication of platelet-lymphocyte ratio and PD-L1 in breast cancer patients. Translational Cancer Research. 7(3). 659–667. 1 indexed citations
15.
Xue, Cong, Wenwen Wei, Peng Sun, et al.. (2018). Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer. Breast Cancer Research and Treatment. 173(3). 619–628. 10 indexed citations
16.
Xia, Wen, Melanie S. Joy, & Lauren M. Aleksunes. (2017). In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants. Pharmaceutical Research. 34(8). 1637–1647. 18 indexed citations
17.
Xia, Wen, Kristin M. Bircsak, Lauren M. Aleksunes, et al.. (2015). Nrf2 Regulates the Sensitivity of Mouse Keratinocytes to Nitrogen Mustard via Multidrug Resistance-Associated Protein 1 (Mrp1). Toxicological Sciences. 149(1). 202–212. 17 indexed citations
18.
Xia, Wen, Brian Buckley, Elizabeth McCandlish, et al.. (2014). Transgenic Expression of the Human MRP2 Transporter Reduces Cisplatin Accumulation and Nephrotoxicity in Mrp2-Null Mice. American Journal Of Pathology. 184(5). 1299–1308. 52 indexed citations
19.
Bao, Fukai, et al.. (2012). Elevated levels of serum IL-32 in patients with active pulmonary tuberculosis. African Journal of Microbiology Research. 6(45). 7292–7294. 7 indexed citations
20.
Xia, Wen. (2009). Effect of Xuefusheng Extract on the Expression of CD28 and CTLA4 on the Surface of T Lymphocytes of Bone Marrow in Severe Aplastic Anemia. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry Hoffman Breakdown of academic impact, for papers by Araba A. Adjei Breakdown of academic impact, for papers by Christelle Cauffiez Breakdown of academic impact, for papers by Alice A. Gibson Breakdown of academic impact, for papers by Nigel T. Brockton Breakdown of academic impact, for papers by Yaping Song Breakdown of academic impact, for papers by Jason R. Manro Breakdown of academic impact, for papers by Daniel J. Crona Breakdown of academic impact, for papers by Delores J. Grant Breakdown of academic impact, for papers by Justin Taylor
Rankless by CCL
2026